BioRestorative Therapies, Inc.
BRTXA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
A recent price could not be verified. Check the exchange before trading.
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
BioRestorative Therapies 1-for-20 reverse split
BioRestorative Therapies common shares will begin trading on a 1-for-20 reverse-split basis on 8 September. The new CUSIP number will be 090655705.
Nasdaq ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.